cGxP.wire https://validator.w3.org/feed/docs/rss2.html Apollo Therapeutics Reports Positive APL-10456 Phase 1 Data SOTIO’s SOT106 ADC Gets FDA Fast Track for Sarcoma Agenus Reports Deep Responses in Neoadjuvant Colon Cancer BioCryst Wins Japan Approval for Pediatric ORLADEYO Autonomix Medical Expands U.S. Patent Protection for Neuromodulation Revolution Medicines Wins FDA Approval for RASONQUE™ in Metastatic Pancreatic Cancer HaemaLogiX Advances KMCAR™ T-Cell Clinical Program Basking Biosciences Reports Positive Phase 1 Data for BB-025 Daiichi Sankyo, AstraZeneca Advance Datroway in Phase 3 Urothelial Cancer Trial INmune Bio Advances Ebstrocel Toward EU Marketing Filing BridgeBio Starts Phase 3b/4 ASCEND-ATTR Acoramidis Study Biohaven, SK Biopharmaceuticals Sign Global Opakalim Deal Cambrex High Point Completes Global FDA Pre-Approval Inspections Eli Lilly Links Zepbound to Lower Healthcare Costs RenovoRx Highlights TAMP Targeted Drug Delivery Data Masimo Gains FDA Clearance for Continuous Oxygen Delivery Monitoring Mend Expands Mend Well Into Chronic Care Management HCW Biologics Advances TGF-β/IL-15 Cancer Immunotherapy Alkermes Publishes Alixorexton Phase 2 Narcolepsy Data Vascarta Advances VAS-101 as Non-Opioid Pain Therapy Savara Highlights Molgramostim Phase 3 Data at ERS 2026 Revier Therapeutics Launches with €6M Cardiometabolic Funding Celea Therapeutics Advances Phase 3 Deupirfenidone Program in IPF Jazz Pharmaceuticals Gains FDA Approval for HER2+ GEA Abbott Gains FDA Authorization for Dual Glucose-Ketone Sensor Summit Advances Ivonescimab in Global HARMONi Trial Sagimet Advances Denifanstat Acne Phase 3 Trial Senhwa Completes CX-5461 Phase 1b Trial Enrollment Mahzi Therapeutics Wins FDA Rare Pediatric Disease Designation Lakefront Biotherapeutics Gains FDA Orphan Status for Gamgertamig Leads Biolabs Advances Opamtistomig Phase II ESCC Study Rhythm Pharmaceuticals Wins Japan Approval for IMCIVREE Caristo Diagnostics to Highlight AI Stroke Prediction at ESC 2026 Hanmi Pharm Licenses Obesity Drug HM17321 to Genentech PTC Therapeutics Highlights Sephience PKU Data at SSIEM 2026 Eisai and Biogen Launch LEQEMBI IQLIK for Alzheimer’s Johnson & Johnson Launches Global DISH Surgical Outcomes System Anixa Biosciences Advances Breast Cancer Vaccine and CAR-T Programs Astellas Starts Phase 3 Trial of ASP2138 in Gastric Cancer Antengene Wins Australian Trial Approval for ATG-201 Vanda Pharmaceuticals Gains EU Orphan Status for Imsidolimab Quest Diagnostics Adds Roche pTau217 Blood Test to AD Portfolio Johnson & Johnson Wins FDA Approval for IMAAVY in wAIHA BeOne Wins FDA Approval for TEVIMBRA HER2+ GEA Regimen Antengene Reports First Profit as Pipeline Advances Henlius Reports 2026 Interim Results, Global Growth Advances Evolved By Nature Peptide Platform Advances Atopic Dermatitis Care ASHP and APhA Call for Stronger Medication Safety Allies of Skin Launches Peptint Tripeptide Lip Treatment AbbVie Highlights Lung Cancer Pipeline Data at WCLC 2026